Barhemsys
Active substance: amisulpride
INJECTION, SOLUTION · AMISULPRIDE 2.5 mg/mL
United StatesActive
Marketing holder: Acacia Pharma Ltd
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- AMISULPRIDE · 2.5 mg/mL
Registration
- Registration number
- 71390-125
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 71390-125 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 71390-125 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 71390-125 · Verified 2026-10-09 · open in source